Maze Therapeutics, Inc. (NASDAQ:MAZE - Get Free Report) insider Atul Dandekar sold 7,500 shares of the business's stock in a transaction dated Friday, August 28th. The shares were sold at an average price of $27.58, for a total value of $206,850.00. Following the completion of the sale, the insider directly owned 26,250 shares of the company's stock, valued at approximately $723,975. This trade represents a 22.22% decrease in their position. The…